Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

International Journal of Endocrinology and Metabolism

Research Institute for Endocrine Sciences

homeHome
play_arrowCurrent IssuelistAll Issuesformat_indent_increaseIn PresssearchSearch
settingsInstructions
bookmarkJournal InformationgroupsBoards and CommitteesshareIndexing and Listing Sourcesshow_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementassignment_indReviewer and AE Registration FormemailSupportphoneContact Us
euroAPC
Authors GuideSubmit Manuscript

Outlines

Body Mass Index in Turner Syndrome Before and After Growth Hormone Therapy

Author(s):
Vakili RVakili Ra,*
International Journal of Endocrinology and Metabolism:Vol. 2, issue 2; 78-81
Published online:Jan 01, 2004
Article type:Research Article
How to Cite:R V. Body Mass Index in Turner Syndrome Before and After Growth Hormone Therapy. Int J Endocrinol Metab. 2004;2(2):. doi:

Abstract

Introduction:

Turner syndrome is the most common chromosomal abnormality in females. Girls with Turner syndrome have an abmormal or missing X choromosme that causes short stature, ovarian failure, renovascular and cardiac anomalies. It has been shown that there is a tendency to obesity in the Turner syndrome. This prospective study has been done to evaluate whether body mass index (BMI) is different in girls with Turner syndrome as compared to normal girls and also whether it is affected by growth hormone (GH) therapy.

Materials and Methods:

Materials and methods: BMI (kg/m2) was calculated for 21 girls with Turner syndrome at baseline (at the diagnosis), and after 6 months treatement with GH D.l IUJkglday subcutaneously at bedtime. The results were analyzed with the SPSS and the statistical significance was established at a p<0.05.

Results:

The mean age at diagnosis was 1l.22.9 years. Height and weight were reduced in Turner syndrome as compared to those of normal girls. BMI's was 18.443.32 and 18.784.21 kglm2 before and after 6-month period of GH therapy, respectively. No significant change in BMI was observed (p=0.334).

Conclusions:

Conclusion: This study documented that shortterm hGH administration was not associated with changes in BMI in girls with Turner syndrome.

Keywords
Turner syndrome
Body mass index
Growth hormone

Full Text

Full text is available in PDF

Similar Articles

31
Dec
2005

Experience With 68 Girls With Turner’s Syndrome and Evaluation of Final Height in 26 Patients Treated With Growth Hormone in Combination or Without Oxandrolone

H Moayeri,
GH Amir

Moayeri H, Amir G. Experience With 68 Girls With Turner’s Syndrome and Evaluation of Final Height in 26 Patients Treated With Growth Hormone in Combination or Without Oxandrolone. Int J Endocrinol Metab. 2005;3(4):e94589. doi:

16
May
2014

Effect of Pubertal Suppression on Linear Growth and Body Mass Index; a Two-Year Follow-Up in Girls with Genetic Short Stature and Rapidly Progressive Puberty

Zohreh Karamizadeh,
Anis Amirhakimi,
Gholamhossein Amirhakimi

Karamizadeh Z, Amirhakimi A, Amirhakimi G. Effect of Pubertal Suppression on Linear Growth and Body Mass Index; a Two-Year Follow-Up in Girls with Genetic Short Stature and Rapidly Progressive Puberty. Inn J Pediatr. 2014;24(3):. doi:

1
Jul
2015

Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls

Kobra Shiasi Arani,
Fatemeh Heidari

Shiasi Arani K, Heidari F. Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls. Int J Endocrinol Metab. 2015;13(3):e23085. doi: https://doi.org/10.5812/ijem.23085v2

7
Dec
2024
Iran J Pediatr

Evaluation of Average Post-menarche Height Growth and Associated Factors: A Cross-Sectional Study

Hamidreza Farahi,
Niki Talebian,
Mahdi Falah Tafti,
Negar Akbarzadeh,
Zahra Razavi

Farahi H, Talebian N, Falah Tafti M, Akbarzadeh N, Razavi Z. Evaluation of Average Post-menarche Height Growth and Associated Factors: A Cross-Sectional Study. Inn J Pediatr. 2025;35(1):e153696. doi: https://doi.org/10.5812/ijp-153696

23
Oct
2020
International Journal of Endocrinology & Metabolism

Effect of Growth Hormone Therapy in Patients with Noonan Syndrome: A Retrospective Study

Louise Jayne Apperley,
Renuka Ramakrishnan,
Poonam Dharmaraj,
Urmi Das,
Mohammed Didi,
Jo Blair
,et al.

Apperley LJ, Ramakrishnan R, Dharmaraj P, Das U, Didi M, et al. Effect of Growth Hormone Therapy in Patients with Noonan Syndrome: A Retrospective Study. Int J Endocrinol Metab. 2020;18(4):e107292. doi: https://doi.org/10.5812/ijem.107292

Import into EndNoteImport into BibTex
Share on
Comments
Number of Comments:0
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles

Related Article in PubMed

Related Article in Google Scholar

Create Citation Alert via Google Reader